| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |